Acadia Pharmaceuticals (ACAD) Work In Process (2018 - 2026)
Acadia Pharmaceuticals' Work In Process was $7.15 million in Q2 2026, up 110.0% from $3.41 million a year earlier and up 49.3% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Work In Process (2018 - 2026) Analysis & Trends
At the end of FY2025, Work In Process at Acadia Pharmaceuticals came in at $2.64 million, up 77.3% from FY2024.
- Work In Process shows a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- In earlier years, Work In Process was $1.49 million in FY2024 (-64.0%), $4.13 million in FY2023 (-6.6%), $4.43 million in FY2022 (-34.6%) and $6.77 million in FY2021 (+6.3%).
- The Q2 2026 figure marks the highest quarterly Work In Process since Q3 2024.
- Compared with a year earlier, Work In Process has increased for three straight quarters, with growth averaging 66.8% over the last eight quarters.
- The best year-over-year quarter for Work In Process over five years was Q3 2024 (growth of 504.3%); the worst was Q3 2025 (a decline of 87.5%).
- Per Business Quant data, ACAD's Work In Process in the three quarters before Q2 2026 was $4.79 million (Q1 2026), $2.64 million (Q4 2025) and $3.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Acadia Pharmaceuticals | 2.95 Bn | -526.50 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.15 Mn |
| Mar 31, 2026 | 4.79 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 25.43 Mn |
| Jun 30, 2024 | 5.36 Mn |
| Mar 31, 2024 | 5.55 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 5.31 Mn |
| Mar 31, 2023 | 4.25 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 4.23 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 5.28 Mn |
| Dec 31, 2021 | 6.77 Mn |
| Sep 30, 2021 | 6.67 Mn |
API Access
Acadia Pharmaceuticals Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();